Ablation Doesn't Lower A-Fib Rates in Wolff-Parkinson-White

Share this content:
Ablation Doesn't Lower A-Fib Rates in Wolff-Parkinson-White
Ablation Doesn't Lower A-Fib Rates in Wolff-Parkinson-White

MONDAY, May 9, 2016 (HealthDay News) -- Patients with Wolff-Parkinson-White (WPW) syndrome who undergo catheter ablation are just as likely as non-ablated patients to develop atrial fibrillation (AF), regardless of age at ablation, according to a study presented at the annual meeting of the Heart Rhythm Society, held from May 4 to 7 in San Francisco.

Jared Bunch, M.D., from the Intermountain Medical Center Heart Institute in Salt Lake City, and colleagues included two WPW populations (872, ablation; 1,461, no ablation) and a 1:5 age- and gender-matched control population (11,175 individuals). WPW patients were followed for a median of 6.9 years.

The researchers found that the risk of incident AF was elevated in the WPW group versus the control group (hazard ratio, 1.55). The risk was lower for non-ablated WPW patients than for ablated patients (hazard ratio, 0.39). Compared with controls, younger ablated WPW patients had significantly higher rates of AF across all age strata, with less risk in older patients with more AF risk factors. Ablation did not lower AF risk across any age strata among WPW patients.

"When a lot of physicians encounter patients with Wolff-Parkinson-White and atrial fibrillation, they believe that if the accessory or extra pathway is treated and cured, then the risk of atrial fibrillation is removed," Bunch said in a statement. "Our findings unfortunately do not confirm that belief and suggest otherwise."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »